Clinical Trials Directory

Trials / Unknown

UnknownNCT06233760

Prevalence of Abuse Among Patients With Rheumatic Diseases

Status
Unknown
Phase
Study type
Observational
Enrollment
244 (estimated)
Sponsor
National Institute of Medical Sciences and Nutrition, Salvador Zubiran · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

Patients with rheumatic diseases (RD) have a relevant representation in the adult population in Mexico. RD are characterized by their chronic and progressive nature, which can impact functionality during the disease and can present various factors that can be associated with the presence of abuse, among others, economic dependence, decreased physical capacity, and need for care and support in different health processes. Regarding abuse in patients with RD, there is little information in the literature; however, it is possible that the prevalence could be similar to that of the occurrence in older adults since both populations share important states of vulnerability. The study aimed to identify the prevalence of abuse in patients with RD. The study will be conducted in two phases: the first one in which the GAS will be adapted for patients with RD, and this version will be validated in a population of our Institute, and the second one in which, applying the validated instrument, the magnitude of abuse is evaluated, and the factors associated with this phenomenon among patients with RD are explored.

Detailed description

Patients with rheumatic diseases (RD) have a relevant representation in the adult population in Mexico. RD are characterized by their chronic and progressive nature, which can impact functionality during the disease and can present various factors that can be associated with the presence of abuse, among others, economic dependence, decreased physical capacity, and need for care and support in different health processes. In 1970, the phenomenon of abuse in geriatric patients was described for the first time as a phenomenon identified as a public health problem and an issue of human rights violation. In 2012 Giraldo-Rodríguez developed and validated the Geriatric Abuse Scale (GAS), an instrument that, with adequate psychometric properties, reported a prevalence of abuse of 10.28% in Mexico. Regarding abuse in patients with RD, there is little information in the literature; however, it is possible that the prevalence could be similar to that of the occurrence in older adults since both populations share important states of vulnerability. The study aimed to identify the prevalence of abuse in patients with RD. The study will be conducted in two phases: the first one in which the GAS will be adapted for patients with RD, and this version will be validated in a population of our Institute, and the second one in which, applying the validated instrument, the magnitude of abuse is evaluated, and the factors associated with this phenomenon among patients with RD are explored.

Conditions

Interventions

TypeNameDescription
OTHERRheumatic diseases Mistreatment Scale (RDMS)In 2012 Giraldo-Rodríguez developed and validated the Geriatric Mistreatment Scale (GAS), prior to its application, translation, cultural adaptation, and validation were performed.
OTHERHealth Assessment Questionnaire (HAQ)The HAQ is based on five patient-centered dimensions: disability, pain, medication effects, costs of care, and mortality
OTHERDepression, Anxiety and Stress Scale (DASS-21)DASS-21 is a set of three self-report scales designed to measure the emotional states of depression, anxiety, and stress. Each of the three DASS-21 scales contains 7 items, divided into subscales with similar content
OTHERBrief Resilient Coping ScaleBrief Resilient Coping Scale is a 4-item measure designed to capture tendencies to cope with stress in a highly adaptive manner
OTHERWHOQOL-BREFWHOQOL-BREF is a 26-item instrument consisting of four domains: physical health, psychological health, social relationships, and environmental health; it also contains QOL and general health items
OTHERRoutine assessment of patient index data 3 (RAPID-3)RAPID- 3 measures: function, pain, and patient global estimate of status. Each of the 3 individual measures is scored 0 to 10, for a total of 30
OTHERBig Five InventoryThe BFI-10 is a 10-item scale measuring the Big Five personality traits Extraversion, Agreeableness, Conscientiousness, Emotional Stability, and Openness.
OTHERFamily APGAR QuestionnaireFamily APGAR questionnaire is used to evaluate family function, in the context of family medical care

Timeline

Start date
2023-04-01
Primary completion
2025-02-01
Completion
2026-03-02
First posted
2024-01-31
Last updated
2024-03-12

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT06233760. Inclusion in this directory is not an endorsement.